Debt-to-equity of PDS Biotechnology Corp from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PDS Biotechnology Corp quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • PDS Biotechnology Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 151%, a 40% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PDS Biotechnology Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 151% +43% +40% 30 Sep 2025
Q2 2025 134% +26% +25% 30 Jun 2025
Q1 2025 118% +10% +9.7% 31 Mar 2025
Q4 2024 108% +7.8% +7.8% 31 Dec 2024
Q3 2024 108% +20% +23% 30 Sep 2024
Q2 2024 107% +35% +48% 30 Jun 2024
Q1 2024 107% +57% +112% 31 Mar 2024
Q4 2023 101% +65% +183% 31 Dec 2023
Q3 2023 88% +69% +359% 30 Sep 2023
Q2 2023 73% +65% +883% 30 Jun 2023
Q1 2023 51% +44% +654% 31 Mar 2023
Q4 2022 36% +29% +419% 31 Dec 2022
Q3 2022 19% +11% +138% 30 Sep 2022
Q2 2022 7.4% 30 Jun 2022
Q1 2022 6.7% 31 Mar 2022
Q4 2021 6.9% 31 Dec 2021
Q3 2021 8% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.